“For Cause” Inspections Find Galloping Clinical Trial Violation Rate
This article was originally published in The Gray Sheet
Executive Summary
The violation rate for clinical trial sponsors shot up in fiscal year 2007, hitting a 10-year high, with FDA finding many of the problems during inspections triggered by complaints, according to CDRH